Abstract We have analyzed the functional significance of the four amino acid differences between the parental H-2Kb and mutant H-2Kbm8 glycoproteins. Six bm8 variants including single substitutions at residues 22, 23, 24, and 30 as well as paired substitutions at residues 23, 30 and 22, 24 were generated and transfected into L cells. Surface expression of these H-2Kb variants was analyzed using monoclonal antibodies which bind to well-defined H-2Kb epitopes. No alterations introduced into the conformational structure of H-2Kb by the amino acid substitutions were detected. The effect of these substitutions on CTL recognition was initially analyzed using the following bulk CTL: either H-2Kb anti-H-2Kbm8, H-2Kbm8 anti-H-2Kb, or third party anti-H-2Kb. The alloreactivity between H-2Kb and H-2Kbm8 is dominated by the amino acid substitution at residue 24 (Glu----Ser). The complete bm8 phenotype, however, also requires the additional substitution at residue 22 (Tyr----Phe). The H-2Kbm8 anti-Kb bulk CTL reacted with both variant H-2Kbm8 molecules containing single substitutions at amino acid positions 22 or 24 but not the variant molecule containing both substitutions. Further analysis using three individual H-2Kbm8 anti-Kb CTL clones indicated the complexity of the self Kbm8 phenotype. Clone 8B1.20 did not react to changes in residues 22 or 24. The 8B1.32 clone reacted with the change at residue 22 but not with the change at residue 24, although the 8B1.54 clone reacted with the change at residue 24 but not with the change at residue 22. The changes in residues 23 (Met----Ile) and/or 30 (Asp----Asn) did not impact significantly on the alloantigenic properties of Kbm8 as determined by both the bulk and cloned CTL populations. According to the three-dimensional class I structure the substitution at amino acid 24 is inaccessible to the TCR. The location of this substitution within the Ag recognition site implies that altered peptide binding, and not a disruption of MHC residues that interact with the TCR, is responsible for the alloreactivity between H-2Kb and H-2Kbm8.
Protein tyrosine phosphorylation and p56
lck
modification in IL-2 or phorbol ester-activated human natural killer cells.
Abstract Protein tyrosine kinases play fundamental roles in the transduction of signals that regulate cell growth, differentiation, and functional responses to a diversity of external stimuli. It is therefore likely that understanding protein tyrosine kinase activity in NK cells will be crucial in further defining the intracellular regulation of their unique and specialized functions. We investigated the role of protein tyrosine phosphorylation in receptor-mediated signal transduction using stimuli known to play major roles in regulating NK cell activation. Immunoblot analyses with antiphosphotyrosine antibodies demonstrated that IL-2, a potent stimulus for NK cell proliferation and an agent that enhances NK cytotoxic function, induced the tyrosine phosphorylation of at least eight proteins in clonal CD16+/CD3-human NK cells. In contrast, IL-4, which modulates NK cell function without inducing proliferation, had no apparent effect on protein tyrosine phosphorylation. Because protein kinase C (PKC) activation plays a prominent, yet distinct role in NK cell-mediated cytolytic reactions, we next investigated whether PKC activation affects NK cell protein tyrosine phosphorylation. Surprisingly, PKC-activating agents, including the phorbol esters 12-O-tetradecanoylphorbol-13-acetate and 4 beta-phorbol 12, 13-didecanoate, as well as the synthetic diacylglycerol,1-oleoyl-2-acetylglycerol, also induced the tyrosine phosphorylation of a distinct set of proteins. The 4 beta-phorbol 12,13-didecanoate homolog, 4 alpha-phorbol 12,13-didecanoate, which does not activate PKC, also failed to induce protein tyrosine phosphorylation. Further, the PKC inhibitor, 1-O-hexadecyl-2-O-methylglycerol blocked tyrosine phosphorylation induced by 1-oleoyl-2-acetylglycerol. In subsequent studies, both CD8+ and CD8- NK clones were found to express the src-family tyrosine kinase, p56lck, which was detected by immunoblot analysis with anti-p56lck antiserum. In both types of clonal NK cell lines, IL-2 and 12-O-tetradecanoyl-phorbol appeared to stimulate the differential phosphorylation of p56lck as evidenced by the appearance of higher molecular mass isoforms on SDS-polyacrylamide gels. Thus, our results identify and characterize a potential role for tyrosine phosphorylation and for the lymphocyte-specific tyrosine kinase p56lck in the signaling events that regulate NK cell activation.
Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.
Abstract Eosinophil granule major basic protein (MBP) and neutrophils have each been implicated in the inflammatory late phase events of allergic disease. Based on this association and flow cytometric evidence presented in this report for MBP binding to neutrophils, we examined the ability of MBP to activate human neutrophils. Incubation of neutrophils with 0.5 to 3.0 microM MBP at room temperature produced a concentration-dependent chemiluminescence (CL) response that peaked after 50 to 70 min. Reduced-and-alkylated MBP, eosinophil cationic protein, and eosinophil-derived neurotoxin did not induce CL. MBP-induced CL was abrogated in the absence of Ca2+ and was absent in neutrophils isolated from two individuals with chronic granulomatous disease. MBP also stimulated release of superoxide anion (O2-) and lysozyme but not beta-glucuronidase or lactate dehydrogenase. Additionally, 1.5 microM MBP in combination with FMLP or platelet-activating factor stimulated a synergistic increase in O2- release from cytochalasin B-treated neutrophils. The degree of synergism with FMLP or platelet-activating factor was inversely related (p less than 0.005) to the level of MBP-induced O2- release. These results indicate that MBP activates neutrophils in a noncytolytic fashion and provide evidence that eosinophil-neutrophil collaboration may contribute to the pathogenesis observed in allergic late phase reactions.
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.
Abstract The effects of therapy with mAb to T cell subsets were studied in mice with Theiler's murine encephalomyelitis virus-induced demyelination. mAb GK1.5 (directed at class II-restricted T cells) and mAb 2.43 (directed at class I-restricted T cells) depleted the appropriate subset of T cells in lymph nodes, spleens, and peripheral blood for 6 to 8 wk after a single i.p. injection of 1 mg of purified mAb. Early treatment with mAb GK1.5 (days -1, 0, and +1 relative to virus injection) resulted in death, encephalitis, and increased demyelination in the majority of animals tested. Treatment with mAb 2.43 resulted in less meningeal inflammation and fewer demyelinating lesions in the spinal cord, irrespective of whether the mAb was given early or after demyelinating disease was established (days 15, 16, and 17). Beneficial response to mAb therapy did not correlate with titers of virus isolated from the central nervous system or serum. These results indicate an important role of class II-restricted T cells during early disease in preventing overwhelming encephalitis; class I-restricted T cells may be critical during demyelination.
The mouse antibody response to
Trichinella spiralis
defines a single, immunodominant epitope shared by multiple antigens.
Abstract Immunoblot analysis was used to characterize the Trichinella spiralis L1 larval Ag recognized by antisera from T. spiralis-infected AKR/J mice. Antisera were analyzed for reactivity with crude worm extract, excretory/secretory proteins and cuticle proteins from L1 larvae. The response was biphasic; antibodies against one set of Ag were detected 13 days after infection (group I Ag), and antibodies against a different set of Ag were detected 35 days after infection (group II Ag). Excretory/secretory and cuticle proteins were recognized only by antibodies produced late in infection. The predominant isotype in day 42 antiserum was IgG1, and 80% of these IgG1 antibodies reacted with a stage-specific determinant shared by virtually all group II Ag. A mAb reactive with the shared determinant was used to purify the group II Ag from L1 larval extract. Such affinity-purified Ag were protective when used to immunize mice against subsequent infection, and T cells from infected mice proliferated when cultured with these Ag in vitro. Other mouse strains also made a strong serum antibody response to the group II Ag. We hypothesize that immune responses to the shared epitope play an important role in determining the outcome of the host-parasite interaction during infection.
Serologic Studies of I-E/I-C Gene Products in Haplotypes H-2b, H-2s, H-2q, and H-2f
Abstract The I-E and I-C subregion products have been identified specifically in haplotypes H-2k and H-2d. Haplotypes H-2p and H-2r are assumed to express products of I-E/I-C subregion on the basis of cross-reactions with anti-I-Ek sera. Anti-I-Ek or I-Ed sera do not cross-react with haplotypes H-2s, H-2b, H-2q, and H-2f. Specific immunizations to produce anti-I-Eb and anti-I-Es alloantisera have been unsuccessful. We turned to xenoimmunization to serologically identify the gene products of this chromosomal segment in the above haplotypes. NP-40 detergent solubilized antigenic material mixed in Freund's complete adjuvant were immunized into rabbits. Two weeks later a booster was given and the rabbits bled one week later for antisera analyses. The rabbits were then boosted once a month and bled periodically. The rabbit antiserum reacted with all mouse strains. Absorptions with appropriate recombinants showed the presence of specific antibodies against the I region products. For example, rabbit anti-B10 serum after absorption with B10.A (3R) left residual activity against B10.A (18R), suggesting antigen(s) mapping between I-J and H-2D. The antiserum was further absorbed with B10.F (13R) to make it specific for I-E/IC subregions. Rabbit anti-B10.M sera, after absorption in ATFR.1 reacts with ATFR.5, suggesting activity in the K and I regions. Since absorption with platelets did not remove activity for spleen cells, presence of anti-If antibodies is suggested. Sequential immunoprecipitation analysis will be performed to screen for anti-I-E/I-C antibodies. Rabbit anti-B10.G and Rabbit anti-B10.S sera are currently being analyzed for I region activity.
Abstract Previous observations from our lab and many others have suggested that MLR determinants are composed of I region gene products. We extended our original observations by studying the reactivities of responder cells obtained after in vitro primary stimulation (primed responder cells = PRC) with selected stimulator cells. These studies suggested that MLR determinants exist as “interaction” products of several I region genes which can act in cis- or trans- position. Furthermore, these studies suggested the existence of specific clones of PRC which could recognize unique F1 MLR determinants. Using serially restimulated PRC which had been in culture for over three months, we derived colonies of alloreactive cells (using soft agar cloning techniques) which have remarkably restricted reactivities. Studies with these “cloned” PRC supported our original premise concerning clones of unique F1 reactive PRC and suggested the existence of unique “homozygous” MLR determinants and clones of cells which specifically recognize such determinants.
Myeloma-Induced Immunosuppression: A Multistep Mechanism
Abstract Hosts of plasma cell tumors have a depressed primary antibody response. We have investigated the ability of cell homogenates and culture fluids from short-term cultures of spleen cells and tumor cells of mice bearing the MOPC-315 plasmacytoma to suppress the in vivo primary antibody response to sheep red blood cells. The homogenates and culture fluids of both MOPC-315 spleen cells and tumor cells suppress the antibody response in a dose-dependent manner. Culture fluids of spleen cells from tumor-bearing mice contain a 10,000- to 20,000-dalton immunosuppressive factor. Culture fluids of non-adherent tumor cells contain a high m.w. suppressor. Injection of the high m.w. tumor suppressive factor into normal mice induces the expression or appearance of host cells that secrete the 10,000- to 20,000-dalton immunosuppressor. The tumor suppressive factor, but not the spleen factor, causes an alteration of lymphocyte membranes such that the anti-DNP activity of the MOPC-315 myeloma protein can be detected on the circulating lymphocytes of injected mice.
Genetic Control of T-Lymphocyte Proliferative Response to Sperm-Whale Myoglobin and Its Synthetic Antigenic Sites in Mice
Abstract Previously we have reported the precise determination of the entire antigenic structure of sperm-whale myoglobin. This protein which is made up on a single polypeptide chain (153 residues, m.w. 17,816) has five antigenic sites located in exposed conformationally sensitive continuous portions of its polypeptide chain. The five antigenic sites occupy the following regions: Site 1: sequence 15–22; Site 2: sequence 56–62; Site 3: sequence 94–99; Site 4: sequence 113–119; Site 5: sequence 145–151. We investigated the genetic control of T lymphocyte proliferative response to myoglobin and its synthetic antigenic sites in mice (PETLES Assay). Two parts of the myoglobin molecule (sequences 1–6 and 121–127) that were not within antigenic sites were also synthesized and employed as controls. Also used as control was a synthetic ‘nonsense’ heptapeptide that did not resemble any part of myoglobin. Haplotypes H-2d, H-2f and H-2s gave substantial T lymphocyte proliferative response to whole myoglobin whereas haplotypes H-2d, H-2k, H-2p, H-2q and H-2r were low responders. Studies with the recombinant strains suggested that expression of a high responder allele in the I-A subregion was enough to give a good proliferative response. On the other hand expression of I-Cd gave a good response while I-Cs gave a poor response. In preliminary studies, mice were primed with whole myoglobin and then challenged in vitro with the synthetic peptides containing the antigenic sites. Among the high responder strains, H-2d haplotype responded to Sites 1, 2, 3 and 5, whereas H-2s and H-2f haplotypes responded only to Sites 1, 2 and 3. We were surprised to find that the low responder strains, haplotypes H-2b, H-2k and H-2r responded to Site 4 but failed to respond to Sites 1, 2, 3 and 5. Mice did not respond to the control peptides. Further studies are currently underway in recombinant strains and in F1 crosses and will be reported at the Ir Gene Workshop. We are also investigating the ability of synthetic antigenic sites in the priming process.
I-C Subregion Determinants on MLR Suppressor Factor
Abstract MLR suppressor factor (MLR-SF) optimally suppresses MLR responses only of responder cells which are compatible in the I-C subregion with cells producing the factor. Therefore, presence of MHC-encoded determinants on MLR-SF has been investigated, with particular interest in I-C, as well as the possible role of I-J determinants. Suppressor activity of supernates of alloantigen-activated spleen cells was tested after passage over solid immunoadsorbants prepared with various anti-H-2 subregion sera. Immunoadsorbants with specificity towards K and D region products were ineffective while several preparations with I region specificity removed suppressor activity from factors of the appropriate haplotype. The single subregion specificity common to all adsorbing preparations was I-C. Recently, ambiguity has developed with regard to genetic resolution of I-C and adjacent subregions, including difficulties of serologic differentiation of I-C products of the k and d haplotypes. Antisera prepared in I-Ck/I-Cd disparate strain combinations have identified T cell restricted determinants which are distinct between these haplotypes. MLR-SF prepared from (BALB × CBA)F1 were passed over I-Cd and I-Ck specific adsorbants and residual activity tested in MLR with each parental responder cell. Exposure to anti-I-Cd removed suppressor activity for the BALB response, leaving intact suppression of CBA responses. The reciprocal situation also obtained. Furthermore, acid elution of anti-I-Cd columns exposed to F1 factor yielded material which suppressed BALB but not CBA MLR. Antisera with anti-I-Jk specificity did not remove suppressor activity of various H-2k factors. In addition, control factors passed over anti-I-Jk columns did not acquire suppressive activity, indicating that leaching of small quantities of anti-I-J antibodies had not concealed actual binding of suppressor molecules, by inducing a distinct form of suppression. Thus, I-C subregion products, restricted to T lymphocyte expression, exhibit unique association with MLR-SF suppression of MHC stimulated immune responses.